logo

Media

BPI signed a cooperation agreement with the University of Balamand in field of Biotechnology

 

BPI hosts "State of the art therapy in Chronic Myeloid Leukemia"

17 Oct 2014

Click for more photos

Under the patronage and the presence of His Excellency the Minister of Public Health Mr. Wael Abou Faour, BPI hosted a conference entitled “State of the Art Therapy in Chronic Myeloid Leukemia” addressed by Professor Hagop Kantarjian, Chairman & Head of Department- Leukemia at MD Anderson Cancer Center, Houston-Texas.



Professor Kantarjian tackled the topics of the Chronic Myeloid Leukemia (CML) Treatment, the response rates achieved with the drugs available, and the methodology of evaluation of response, in addition to the mechanisms of resistance with the mutations available and how to overcome them. Also, he addressed the issue of the first line therapy with “Imatinib” and the latest drugs in the market and most importantly when to switch therapies.


Mr. Wael Abou Faour awarded Professor Kantarjian a gold medal from the Lebanese Ministry of Public Health.



Mr. Bernard Tannoury, CEO & Chairman of BPI, affirmed the company’s persistence in the continuous development of its high tech facilities and its perseverance in the production of a wide range of high quality pharmaceutical products including biotechnology, sterile and oncology products distributed to the Lebanese and international markets.



Oncologists, Hematologists, hospital pharmacists and government officials attended the event that took place at the Yacht Club- Zaytouna Bay, Beirut on Friday October 17, 2014.